Aptevo Therapeutics Inc.

APVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
ARS Jul 3, 2025 ARS
8-K Jul 1, 2025 8-K
8-K Jun 30, 2025 8-K
SCHEDULE 13G Jun 25, 2025
SCHEDULE 13G Jun 25, 2025
PRE 14A Jun 23, 2025 PRE 14A
SCHEDULE 13G Jun 23, 2025
SCHEDULE 13G/A Jun 23, 2025
8-K Jun 23, 2025 8-K
8-K Jun 20, 2025 8-K
424B5 Jun 20, 2025 424B5
8-K Jun 20, 2025 8-K
424B4 Jun 20, 2025 424B4
EFFECT Jun 18, 2025
S-1MEF Jun 18, 2025 S-1MEF
8-K Jun 17, 2025 8-K
CORRESP Jun 16, 2025
S-1 Jun 16, 2025 S-1
UPLOAD Jun 4, 2025
DRS May 30, 2025
424B3 May 28, 2025 424B3
8-K May 23, 2025 8-K
EFFECT May 22, 2025
8-K May 22, 2025 8-K
424B5 May 22, 2025 424B5
← Newer Page 5 of 30 · 730 filings Older →